Genomics & Informatics

  • 제11권1호
  • /
  • Pages.34-37
  • /
  • 2013
  • /
  • 1598-866X(pISSN)
  • /
  • 2234-0742(eISSN)
한국유전체학회 (Korea Genome Organization)
권호 표지
DOI QR코드

DOI QR Code

Effects of Somatic Mutations Are Associated with SNP in the Progression of Individual Acute Myeloid Leukemia Patient: The Two-Hit Theory Explains Inherited Predisposition to Pathogenesis

  • Park, Soyoung (Cancer Research Institute, Seoul National University College of Medicine) ;
  • Koh, Youngil (Cancer Research Institute, Seoul National University College of Medicine) ;
  • Yoon, Sung-Soo (Cancer Research Institute, Seoul National University College of Medicine)
  • 투고 : 2013.01.18
  • 심사 : 2013.02.20
  • 발행 : 2013.03.31
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

This study evaluated the effects of somatic mutations and single nucleotide polymorphisms (SNPs) on disease progression and tried to verify the two-hit theory in cancer pathogenesis. To address this issue, SNP analysis was performed using the UCSC hg19 program in 10 acute myeloid leukemia patients (samples, G1 to G10), and somatic mutations were identified in the same tumor sample using SomaticSniper and VarScan2. SNPs in KRAS were detected in 4 out of 10 different individuals, and those of DNMT3A were detected in 5 of the same patient cohort. In 2 patients, both KRAS and DNMT3A were detected simultaneously. A somatic mutation in IDH2 was detected in these 2 patients. One of the patients had an additional mutation in FLT3, while the other patient had an NPM1 mutation. The patient with an FLT3 mutation relapsed shortly after attaining remission, while the other patient with the NPM1 mutation did not suffer a relapse. Our results indicate that SNPs with additional somatic mutations affect the prognosis of AML.

키워드

참고문헌

  1. Grossmann V, Tiacci E, Holmes AB, Kohlmann A, Martelli MP, Kern W, et al. Whole-exome sequencing identifies somatic mutations of BCOR in acute myeloid leukemia with normal karyotype. Blood 2011;118:6153-6163. https://doi.org/10.1182/blood-2011-07-365320
  2. Song JH, Kim SH, Kweon SH, Lee TH, Kim HJ, Kim TS, et al. Defective expression of deoxycytidine kinase in cytarabine-resistant acute myeloid leukemia cells. Int J Oncol 2009;34: 1165-1171.
  3. Tucker T, Friedman JM. Pathogenesis of hereditary tumors: beyond the "two-hit" hypothesis. Clin Genet 2002;62:345-357. https://doi.org/10.1034/j.1399-0004.2002.620501.x
  4. Liang H, Zhang J, Shao C, Zhao L, Xu W, Sutherland LC, et al. Differential expression of RBM5, EGFR and KRAS mRNA and protein in non-small cell lung cancer tissues. J Exp Clin Cancer Res 2012;31:36. https://doi.org/10.1186/1756-9966-31-36
  5. Pezzi A, Moraes L, Valim V, Amorin B, Melchiades G, Oliveira F, et al. DNMT3A mutations in patients with acute myeloid leukemia in South Brazil. Adv Hematol 2012;2012:697691.
  6. Smith CC, Wang Q, Chin CS, Salerno S, Damon LE, Levis MJ, et al. Validation of ITD mutations in FLT3 as a therapeutic target in human acute myeloid leukaemia. Nature 2012;485: 260-263. https://doi.org/10.1038/nature11016
  7. Dohner K, Schlenk RF, Habdank M, Scholl C, Rucker FG, Corbacioglu A, et al. Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: interaction with other gene mutations. Blood 2005;106:3740-3746. https://doi.org/10.1182/blood-2005-05-2164

피인용 문헌

  1. Identification of somatic mutations using whole-exome sequencing in Korean patients with acute myeloid leukemia vol.18, pp.1, 2017, https://doi.org/10.1186/s12881-017-0382-y